Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial | Clinical Pharmacy and Pharmacology | JAMA

This platform randomized clinical trial examines the effectiveness ivermectin at a targeted dose of 600 μg/kg daily compared with placebo for the treatment of e

Related Keywords

United States ,Cincinnati ,Ohio ,American ,Pardes Biosciences ,Susanna Naggie ,Bristol Myers Squibb ,Amgen ,Department Of Defense ,Translational Sciences ,Pfizer ,Us Biomedical Advanced Research Development Authority ,Astrazeneca ,Vanderbilt University Medical Center Clinical ,Endpoint Health ,Assembly Bio ,Faron Pharmaceuticals ,Health Sciences ,Centers For Disease ,Entegrion Inc ,National Institutes Of Health ,Biomedical Advanced Research ,Duke Clinical Research Institute ,Development Authority ,Cincinnati Children Hospital Medical Center ,Duke University ,Duke University School Of Medicine ,Genentech ,Merck Co ,Novartis ,University Of Pittsburgh ,Gilead Sciences ,National Center ,Government Services ,Health Insights ,Enanta Pharmaceuticals ,Abdominal Core Health Quality Collaborative ,Office Of The ,Drug Administration Emergency Use Authorization ,Progression Scale ,Analysis Plan ,African American ,Treatment Effect Analyses ,Duke University School ,Drs Lindsell ,Interest Disclosures ,National Institutes ,Silverback Therapeutics ,Vir Biotechnology ,Personal Health Insights ,Bristol Myers ,Advancing Translational Sciences ,Cincinnati Children ,Hospital Medical Center ,Bioscape Digital ,Viiv Healthcare ,Precision Bio ,Viral Hepatitis ,Operation Warp Speed ,Advanced Research ,Tunnell Government Services ,Disease Control ,Gala Therapeutics ,Pioneering Medicines ,Aer Therapeutics ,Assistant Secretary ,Translational Science Award ,